Please login to the form below

Not currently logged in
Email:
Password:

RSV trial

This page shows the latest RSV trial news and features for those working in and with pharma, biotech and healthcare.

Pfizer starts RSV trial ahead of winter season

Pfizer starts RSV trial ahead of winter season

Earlier this year, AstraZeneca and Sanofi’s long-acting antibody nirsevimab met the primary endpoint in a late-stage respiratory syncytial virus (RSV) trial in healthy infants. ... Janssen also has a phase 3 trial looking at its vaccine candidate, Ad26

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...